{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-013119","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.247491+00:00","generated_at":"2026-06-03T08:56:41.292995+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ultralife Q1 sales up 31.4% to $41.9M; GAAP EPS $0.18 vs -$0.02 YoY","bullets":["Revenue $41.9M (+31.4% YoY); government/defense sales +83.4%, medical battery sales +54.7%.","GAAP EPS $0.18 vs net loss $0.02; adjusted EPS $0.21. Operating income $4.1M vs breakeven.","Gross margin 27.4% vs 23.3% YoY; Battery & Energy margin 25.7% vs 22.9%.","Backlog $97.4M; adjusted EBITDA $5.2M (12.5% of sales) vs $1.2M (3.6%).","CEO cites gross margin initiatives and core product demand; expects profitable growth and cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-013119","json":"https://secwatch.observer/filing/0001437749-24-013119.json","markdown":"https://secwatch.observer/filing/0001437749-24-013119.md","text":"https://secwatch.observer/filing/0001437749-24-013119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/0001437749-24-013119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/ulbi20240424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T08:56:41.292995+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e240a3f4fa0f140051e9a002cc0bbc396984cac2","claim":"ULTRALIFE CORP reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On April 25, 2024, Ultralife Corporation issued a press release regarding the financial results for its first quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/0001437749-24-013119-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}